Warren C. Naselsky

Transglutaminase 2 Maintains Hepatocyte Growth Factor Signaling to Enhance the Cancer Cell Phenotype

R. Eckert, Wen Xu, Xi Chen, 2021, Molecular Cancer Research.

ACTL6A suppresses p21Cip1 tumor suppressor expression to maintain an aggressive mesothelioma cancer cell phenotype

R. Eckert, J. Friedberg, Wen Xu, 2021, Oncogenesis.

Transglutaminase 2 enhances hepatocyte growth factor signaling to drive the mesothelioma cancer cell phenotype

Xi Chen, R. Eckert, J. Friedberg, 2022, Molecular carcinogenesis.

Mast Cell Deficiency Limits the Development of Chronic Rhinosinusitis in Mice

X. Hua, S. Graham, B. Senior, 2016, The Annals of otology, rhinology, and laryngology.

The transglutaminase 2 cancer cell survival factor maintains mTOR activity to drive an aggressive cancer phenotype

Xi Chen, R. Eckert, Wen Xu, 2022, Molecular carcinogenesis.

IL-4 Amplifies the Pro-Inflammatory Effect of Adenosine in Human Mast Cells by Changing Expression Levels of Adenosine Receptors

X. Hua, S. Tilley, K. Chason, 2011, PloS one.

Adenosine increases nasal mucociliary clearance rate in mice through A2A and A2B adenosine receptors

X. Hua, C. Ledent, W. Bennett, 2013, The Laryngoscope.